Tilray Brands (TLRY) Profit After Tax (2017 - 2026)
Tilray Brands (TLRY) reported Profit After Tax of -$26.6 million for Q1 2026, up 96.65% on a YoY basis from -$13.5 million in Q1 2025, and up 40.86% quarter-over-quarter from -$44.9 million in Q4 2025.
Tilray Brands (TLRY) Profit After Tax (2017 - 2026) Analysis & Trends
Tilray Brands has reported Profit After Tax for 10 years, with the latest figure at -$26.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 96.65% year-over-year to -$26.6 million; the trailing twelve-month figure through Feb 2026 stood at -$1.3 billion (down 44.3% YoY), and the FY2025 full-year result was -$2.2 billion, down 880.81% from the prior year.
- Profit After Tax for Q1 2026 stood at -$26.6 million, up from -$44.9 million in the prior quarter.
- The five-year high for Profit After Tax was $43.2 million in Q1 2022, with the low at -$1.3 billion in Q2 2025.
- Historically, Profit After Tax has averaged -$258.0 million across 5 years, with a median of -$61.6 million in 2022.
- Annual changes were most pronounced in 2022 — Profit After Tax jumped 116.7% — and 2025, when it tumbled 13726.55%.
- Tilray Brands' Profit After Tax stood at -$61.6 million in 2022, then gained by 25.07% to -$46.2 million in 2023, then sank by 84.65% to -$85.3 million in 2024, then jumped by 47.31% to -$44.9 million in 2025, then surged by 40.86% to -$26.6 million in 2026.
- The last three Profit After Tax figures came in at -$26.6 million (Q1 2026), -$44.9 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | -26.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -26.57 Mn |
| Nov 30, 2025 | -44.93 Mn |
| Aug 31, 2025 | 1.51 Mn |
| May 31, 2025 | -1.27 Bn |
| Feb 28, 2025 | -793.53 Mn |
| Nov 30, 2024 | -85.28 Mn |
| Aug 31, 2024 | -39.17 Mn |
| May 31, 2024 | -9.17 Mn |
| Feb 29, 2024 | -92.70 Mn |
| Nov 30, 2023 | -46.18 Mn |
| Aug 31, 2023 | -55.86 Mn |
| May 31, 2023 | -138.71 Mn |
| Feb 28, 2023 | -1.20 Bn |
| Nov 30, 2022 | -61.64 Mn |
| Aug 31, 2022 | -73.48 Mn |
| May 31, 2022 | -500.47 Mn |
| Feb 28, 2022 | 43.19 Mn |
| Nov 30, 2021 | 5.80 Mn |
| Aug 31, 2021 | -34.60 Mn |
| May 31, 2021 | 47.20 Mn |